Access cutting-edge cystic fibrosis treatment through this clinical trial at a research site in Kansas City. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Kansas City location
Access cystic fibrosis specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cystic fibrosis treatment provided free
Check if you qualify for this cystic fibrosis clinical trial in Kansas City, KS
No-Cost Study Care
Local to Kansas City
Convenient for KS residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
CMTX-101 is a bacterial biofilm disrupting monoclonal antibody being developed as an adjunctive therapy to standard of care antibiotics. The goal of this clinical trial is to assess the safety and tolerability of CMTX-101 in people with cystic fibrosis (pwCF). The main questions the study aims to answer are: * Are single doses of CMTX-101 IV infusion safe and tolerated * What is the pharmacokinetic (PK) profile of single doses of CMTX-101 * Do single doses of CMTX-101 induce development of ant
Sponsor: Clarametyx Biosciences, Inc.
Yes, this clinical trial (NCT06159725) has an active research site in Kansas City, KS that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for cystic fibrosis treatment options in Kansas City, KS, this clinical trial (NCT06159725) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Kansas City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cystic fibrosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all cystic fibrosis clinical trials near you to find additional studies recruiting in your area.
See all cystic fibrosis clinical trials recruiting in Kansas City — not just this study.
Browse Cystic Fibrosis Trials in Kansas City →